You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
The NeuroblastomaPSM (Neuroblastoma Partitioned Survival Model) package documents the cost effectiveness of Dinutuximab Beta (Qarziba®) for the treatment of high-risk neuroblastoma patients after stem cell transplantation.